These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 3938075

  • 1. Chelatotherapy in multiple sclerosis. Open preliminary study of a new therapeutical principle applied in multiple sclerosis--public health topic.
    Dinu R, Dinu I.
    Sante Publique (Bucur); 1985; 28(1):3-30. PubMed ID: 3938075
    [No Abstract] [Full Text] [Related]

  • 2. Herpes zoster and herpes simplex--public health matter; chelatotherapy in these acute neuroviroses.
    Dinu R, Dinu I.
    Sante Publique (Bucur); 1984; 27(2):99-114. PubMed ID: 6441289
    [No Abstract] [Full Text] [Related]

  • 3. Augmentation of CD8 and CD4 lymphocytes subsets in AIDS infected children after treatment with a non-toxic chelating agents compound--Rodilemid.
    Dinu R, Moraru I, State D, Dinu I.
    Rom J Intern Med; 1995; 33(3-4):205-10. PubMed ID: 8646193
    [Abstract] [Full Text] [Related]

  • 4. Rodilemid therapy in peripheral palsy: a clinical and electrophysiological study.
    Dinu R, Csiki IE, Negoescu R.
    Neurol Psychiatr (Bucur); 1986; 24(4):263-8. PubMed ID: 3101162
    [No Abstract] [Full Text] [Related]

  • 5. [Multiple sclerosis. A new oral immunomodulator].
    Med Monatsschr Pharm; 2005 Oct; 28(10):372. PubMed ID: 16245463
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mitoxantrone (Novantrone) in multiple sclerosis: new insights.
    Neuhaus O, Kieseier BC, Hartung HP.
    Expert Rev Neurother; 2004 Jan; 4(1):17-26. PubMed ID: 15853611
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preliminary reports on a therapeutical trial in multiple sclerosis.
    Floris V, Spadaro M, Tilia G.
    Riv Neurol; 1987 Jan; 57(3):185-8. PubMed ID: 3313667
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbation.
    Rose AS, Kuzma JW, Kurtzke JF, Sibley WA, Tourtellotte WW.
    Trans Am Neurol Assoc; 1969 Jan; 94():126-33. PubMed ID: 4313957
    [No Abstract] [Full Text] [Related]

  • 13. Trial tests chelation's effect on heart disease.
    Bonetta L.
    Nat Med; 2002 Sep; 8(9):906-7. PubMed ID: 12205436
    [No Abstract] [Full Text] [Related]

  • 14. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
    Stark Y.
    Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251
    [No Abstract] [Full Text] [Related]

  • 15. [Corticosteroid therapy of disseminated sclerosis].
    Lobzin VS, Bardasarova IA, Golovkin VI.
    Sov Med; 1985 Jul; (9):105-9. PubMed ID: 3906928
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of multiple sclerosis with a synthetic polypeptide: preliminary results.
    Bornstein MB, Miller AE, Teitelbaum D, Arnon R, Sela M.
    Trans Am Neurol Assoc; 1980 Jul; 105():348-50. PubMed ID: 6758285
    [No Abstract] [Full Text] [Related]

  • 17. Humanized anti-CD25 antibody treatment with daclizumab in multiple sclerosis.
    Martin R.
    Neurodegener Dis; 2008 Jul; 5(1):23-6. PubMed ID: 18075271
    [Abstract] [Full Text] [Related]

  • 18. Copolymer 1 from the laboratory to FDA.
    Teitelbaum D, Sela M, Arnon R.
    Isr J Med Sci; 1997 Apr; 33(4):280-4. PubMed ID: 9347880
    [No Abstract] [Full Text] [Related]

  • 19. Multiple sclerosis: trial of a synthetic polypeptide.
    Bornstein MB, Miller AI, Teitelbaum D, Arnon R, Sela M.
    Ann Neurol; 1982 Mar; 11(3):317-9. PubMed ID: 7092185
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D as an immune modulator in multiple sclerosis, a review.
    Smolders J, Damoiseaux J, Menheere P, Hupperts R.
    J Neuroimmunol; 2008 Feb; 194(1-2):7-17. PubMed ID: 18177949
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.